In this Review, Lujambio and colleagues provide an overview of the use of in vitro and in vivo precision models for hepatocellular carcinoma, their strengths and limitations, and how they can be used to identify and test precision therapies and biomarkers.
- Marina Barcena-Varela
- Satdarshan P. Monga
- Amaia Lujambio